Anti-tumor effects of bemiparin in HepG2 and MIA PaCa-2 cells.

Alur, Ihsan; Dodurga, Yavuz; Seçme, Mücahit; Elmas, Levent; Bagci, Gülseren; Göksin, Ibrahim; Avci, Çigir Biray

Alur, Ihsan; Dodurga, Yavuz; Seçme, Mücahit; Elmas, Levent; Bagci, Gülseren; Göksin, Ibrahim; Avci, Çigir Biray.

Afiliação

Alur I; Department of Cardiovascular Surgery, Pamukkale University, Faculty of Medicine, Denizli, Turkey.
Dodurga Y; Department of Medical Biology and Genetics, Pamukkale University, Faculty of Medicine, Denizli, Turkey. Electronic address: yavuzdodurga@gmail.com.
Seçme M; Department of Medical Biology and Genetics, Pamukkale University, Faculty of Medicine, Denizli, Turkey.
Elmas L; Department of Medical Biology and Genetics, Pamukkale University, Faculty of Medicine, Denizli, Turkey.
Bagci G; Department of Medical Biology and Genetics, Pamukkale University, Faculty of Medicine, Denizli, Turkey.
Göksin I; Department of Cardiovascular Surgery, Pamukkale University, Faculty of Medicine, Denizli, Turkey.
Avci ÇB; Department of Medical Biology and Genetics, Ege University, Faculty of Medicine, Izmir, Turkey.

Gene ; 585(2): 241-6, 2016 Jul 10.

Article em En | MEDLINE | ID: mdl-27048831

Assuntos

Antineoplásicos/farmacologia; Heparina de Baixo Peso Molecular/farmacologia; Apoptose/efeitos dos fármacos; Linhagem Celular Tumoral; Genes cdc/efeitos dos fármacos; Humanos

Palavras-chave

Bemiparin; HepG2; MIA PaCa-2

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Heparina de Baixo Peso Molecular / Antineoplásicos Limite: Humans Idioma: En Revista: Gene Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Turquia País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google